.

Anika Therapeutics reported $21.27M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agenus AGEN:US $ 18.91M 39K
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Chemocentryx CCXI:US $ 28.18M 2.17M
Clovis Oncology CLVS:US $ 32.59M 3.38M
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Heron Therapeutics HRTX:US $ 32.12M 836K
Immunogen IMGN:US $ 23.79M 7.14M
Insmed INSM:US $ 59.97M 3.23M
Integra Lifesciences IART:US $ 157.99M 6.97M
Intrexon XON:US $ 12.67M 6.91M
Johnson & Johnson JNJ:US $ 6.23B 288M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Macrogenics MGNX:US $ 13.67M 2.58M
Merit Medical Systems MMSI:US $ 85.49M 1.47M
Peregrine Pharmaceuticals PPHM:US $ 6.38M 467K
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Stryker SYK:US $ 1.46B 44M
Surmodics SRDX:US $ 12.85M 1.74M
Veracyte VCYT:US $ 39.96M 4.18M
Xencor XNCR:US $ 11.09M 182K
Zimmer Biomet Holdings Inc ZBH:US $ 695.2M 10.7M